Pernix therapeutics 10k
WebApr 24, 2015 · Contacts. Pernix Therapeutics Holdings, Inc. Investor Relations In-Site Communications Lisa Wilson, 212-452-2793 [email protected] or Media Relations Marianne Lambertson, (800) 793-2145 ext ... WebThese reports include company annual reports (10K, 10Q), news updates (8K), investor presentations (found in 8Ks), insider trades (form 4), ownership reports (13D, and 13G), …
Pernix therapeutics 10k
Did you know?
WebAdditional information about Pernix is available on the Company's website located at www.pernixtx.com. CONTACT: Pernix Therapeutics Holdings, Inc. Joseph T. Schepers, 800-793-2145, ext. 3002 Director, Investor Relations [email protected] WebJun 2, 2016 · The past two months have not been good for Pernix Therapeutics (NYSEMKT:PTX-OLD).After missing fourth quarter earnings by nearly 59 times the estimate, the stock has seen a steady decline from ...
WebNov 14, 2012 · Pernix Therapeutics is a specialty pharmaceutical company primarily focused on the sales, marketing, manufacturing and development of branded, generic and OTC pharmaceutical products. ... Investors should note that many factors, as more fully described under the caption "Risk Factors" in our Form 10-K, Form 10-Q and Form 8-K … WebApr 11, 2024 · Pernix Therapeutics Holdings, Inc. (“Pernix” or the “Company”) (NASDAQ MKT: PTX), a specialty pharmaceutical company, today announced that it has closed on the sale of its Houston, TX-based manufacturing operations, Pernix Manufacturing, LLC (“PML”) to Woodfield Pharmaceutical LLC (“Woodfield”). As previously announced ...
WebMar 6, 2013 · Pernix Therapeutics is a specialty pharmaceutical company primarily focused on the sales, marketing, manufacturing and development of branded, generic and OTC pharmaceutical products. The... http://filings.irdirect.net/data/1024126/000135448815000878/ptx_10k.pdf
WebMar 28, 2024 · Pernix Therapeutics Holdings, Inc. (PTX) SEC Filing 10-K Annual report for the fiscal year ending Saturday, December 31, 2016
http://cavionpharma.com/ fcfcu hoursWebEarnings Press Release 10-K Annual Report 10-K YoY Changes Pernix Therapeutics Holdings, Inc. CIK: 1024126 Ticker: PTX Exhibit 99.1 Pernix Therapeutics Reports Fourth … Pernix Therapeutics Holdings, Inc. (PTX) 10-K Annual Report Wed Feb 24 2010; SE… fcfcu bethlehem paWebAs previously announced, on February 18, 2024, Pernix Therapeutics Holdings, Inc. (“Pernix” or the “Company”) and Pernix’s wholly-owned subsidiaries filed voluntary petitions for … fcfcu indianapolis credit unionWebFeb 14, 2024 · Founded in 1996, Pernix Therapeutics is a specialty pharmaceutical company developing and commercializing products for the treatment of central nervous system indications, including pain,... fcfc shopWebNov 14, 2012 · Under the terms of the agreement, Pernix will pay approximately $101 million, which includes an up-front payment of $68.5 million in cash and $12.5 million in equity, $10 million payable in... frith photos historyWebDec 10, 2012 · I and Somaxon Pharmaceuticals, Inc from PERNIX THERAPEUTICS HOLDINGS, INC. filed with the Securities and Exchange Commission. Log In Sign Up. Find a Lawyer; Ask a Lawyer ; Research the Law; Law Schools ... 2011 included in the Company’s annual report filed on Form 10-K for the year ended December 31, 2011, including the … frith psychiatryWebPernix Therapeutics Holdings (Pernix) (NASDAQ: PTX) was a publicly traded specialty pharmaceutical company primarily focused on the sales, marketing, and development of … fcfcu locations indianapolis